IMMUNITYBIO, INC. (IBRX) Shareholders’ equity 2016–2025
IMMUNITYBIO, INC. (IBRX) shareholders’ equity at each fiscal year-end, per SEC filings.
-$500.5MFY2025 · since FY2016: $293.4M → -$500.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$500.5M | -2.3% |
| FY2024 | -$489.1M | +16.7% |
| FY2023 | -$587.0M | -31.2% |
| FY2022 | -$447.3M | -84.7% |
| FY2021 | -$242.2M | -102.1% |
| FY2020 | -$119.8M | -833.8% |
| FY2019 | $16.3M | -80.1% |
| FY2018 | $81.9M | -62.6% |
| FY2017 | $218.8M | -25.4% |
| FY2016 | $293.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice